Masimo Co. (NASDAQ:MASI) Insider Jon Coleman Sells 2,000 Shares

Masimo Co. (NASDAQ:MASI) insider Jon Coleman sold 2,000 shares of Masimo stock in a transaction dated Friday, January 18th. The stock was sold at an average price of $120.00, for a total value of $240,000.00. Following the transaction, the insider now directly owns 13,201 shares in the company, valued at $1,584,120. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

Jon Coleman also recently made the following trade(s):

  • On Thursday, January 31st, Jon Coleman sold 2,000 shares of Masimo stock. The shares were sold at an average price of $125.00, for a total value of $250,000.00.
  • On Tuesday, January 15th, Jon Coleman sold 2,000 shares of Masimo stock. The shares were sold at an average price of $115.00, for a total value of $230,000.00.

Masimo stock opened at $128.43 on Thursday. Masimo Co. has a 1-year low of $81.56 and a 1-year high of $130.00. The firm has a market capitalization of $6.88 billion, a price-to-earnings ratio of 52.42, a price-to-earnings-growth ratio of 2.70 and a beta of 1.07.

Large investors have recently bought and sold shares of the stock. Ruggie Capital Group acquired a new stake in shares of Masimo during the 4th quarter worth approximately $33,000. Quantamental Technologies LLC acquired a new position in shares of Masimo in the fourth quarter valued at approximately $43,000. Financial Gravity Companies Inc. bought a new position in shares of Masimo during the 4th quarter worth approximately $49,000. First Hawaiian Bank raised its position in Masimo by 170.0% in the 4th quarter. First Hawaiian Bank now owns 1,080 shares of the medical equipment provider’s stock valued at $116,000 after buying an additional 680 shares during the last quarter. Finally, Bogart Wealth LLC increased its position in shares of Masimo by 13.7% during the 4th quarter. Bogart Wealth LLC now owns 1,161 shares of the medical equipment provider’s stock valued at $124,000 after purchasing an additional 140 shares during the last quarter. Institutional investors and hedge funds own 87.36% of the company’s stock.

Several research firms have recently issued reports on MASI. Zacks Investment Research upgraded shares of Masimo from a “sell” rating to a “hold” rating in a report on Wednesday, January 23rd. Piper Jaffray Companies upgraded Masimo from a “neutral” rating to an “overweight” rating and set a $120.00 price objective for the company in a research report on Wednesday, December 19th. BidaskClub raised Masimo from a “hold” rating to a “buy” rating in a research note on Thursday, December 13th. Needham & Company LLC reissued a “buy” rating and issued a $139.00 price target on shares of Masimo in a report on Friday, February 1st. Finally, UBS Group started coverage on shares of Masimo in a research report on Tuesday, November 27th. They set a “buy” rating and a $137.00 price objective on the stock. One equities research analyst has rated the stock with a hold rating, seven have issued a buy rating and one has issued a strong buy rating to the company. Masimo currently has an average rating of “Buy” and an average price target of $121.86.

ILLEGAL ACTIVITY WARNING: This article was first posted by Baseball Daily News and is the sole property of of Baseball Daily News. If you are reading this article on another domain, it was stolen and reposted in violation of US and international copyright & trademark law. The legal version of this article can be read at https://www.baseballdailydigest.com/news/2019/02/14/masimo-co-masi-insider-jon-coleman-sells-2000-shares.html.

Masimo Company Profile

Masimo Corporation, a medical technology company, develops, manufactures, and markets noninvasive monitoring technologies worldwide. The company offers Masimo Signal Extraction Technology (SET) pulse oximetry with measure-through-motion and low-perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry.

Featured Story: What are the most popular ETFs

Insider Buying and Selling by Quarter for Masimo (NASDAQ:MASI)

Receive News & Ratings for Masimo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply